Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells for Promoting Corneal Repair

NCT04626583 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT04626583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04626583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells for Promoting Corneal Repair
Lead sponsor
University of Illinois at Chicago
Phase
Phase 1
Overall status
Completed
Start date
March 5, 2021
Completion date
April 21, 2023
Enrollment
8 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cornea, corneal defect, mesenchymal stromal cells, safety